|Last Price$46.85||Day Change (%)-0.32%|
|Open Price$47.02||Day Change ($)-0.15|
|Day Range46.78–47.21||52-Week Range38.25–48.62|
As of Tue 5/5/2015 6:30:00 PM | USD
A group of top managers continue to keep looking for good investment opportunities, while taking full advantage of a rising (and potentially overvalued) market to book some gains.
Research and Markets: Global Home Healthcare Global Market 2015 - Forecast to 2020
Simple formulas for foreign exposure lose luster.
Neos Therapeutics, Inc. Appoints Thomas P. McDonnell As Chief Commercial Officer
Makers of Baby Formula Press Their Case on WIC Program
AbbVie Presents Late-Breaking, Preliminary Phase 3b Data with VIEKIRAX® + EXVIERA® in Chronic Hepatitis C Patients with Renal Impairment at The International Liver Congress™ 2015
The Rise of the 'Stichting,' an Obscure Takeover Defense
U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 4 Chronic Hepatitis C
Research and Markets: Abbott Diagnostics: Company Profile 2015
AbbVie's Investigational Chronic Hepatitis C Treatment Granted Priority Review in Japan